Sage Journals: Discover world-class research

Abstract

The authors recently cloned a cDNA for an ICE/CED3-related cysteine protease from rat brain, which is closely related to human CPP32 (now designated caspase-3). In situ hybridization histochemistry revealed a profound developmental regulation of the caspase-3 transcript in rat brain, with relatively high levels of caspase-3 mRNA observed in neurons of the fetal and neonatal brain and low levels of mRNA in neurons of the adult brain. The authors report that transient forebrain ischemia, which results in a delayed apoptotic death of CA1 pyramidal neurons, results in prolonged expression of caspase-3 mRNA in these same pyramidal neurons. Up-regulation of caspase-3 mRNA in CA1 pyramidal neurons is prominent 24 hours after transient global ischemia, and expression is maintained at higher levels for at least 72 hours after ischemia. However, by 96 hours after ischemia, a marked decrease in caspase-3 mRNA expression is observed in CA1 pyramidal neurons, showing severe degenerative changes (e.g., nuclear condensation). By contrast, there is no change in the expression of a closely related member of caspase family, caspase-2, in CA1 pyramidal neurons after global ischemia. Instead, caspase-2 mRNA is induced in lamina layers of cerebral cortex 24 hours after the ischemia. A selective and prolonged induction of the caspase-3 gene in committed CA1 pyramidal neurons suggests that transcriptional activation of this caspase-3 gene may be involved in the apoptotic cell death cascade of CA1 neurons after transient global ischemia.

Keywords

Caspase-3 Cell death Ischemia

Apoptosis is a physiologic mechanism by which a cell dies through activation of an intrinsic cell death or suicide program (for review see Vaux and Strasser, 1996; Jacobson et al., 1997). Activation of this cell death program leads to a cascade of intracellular events that includes a commitment point, followed by the appearance of characteristic ultrastructural changes in the nucleus, cell death, and eventually, phagocytosis (Kerr et al., 1972). Recent studies have provided strong evidence that apoptotic cell death not only is required for normal central nervous system development (Raff et al., 1993; Saunders, 1996), but it also is involved in the pathologic death of neurons that occurs in various neurodegenerative disorders, such as Alzheimer's disease, and ischemic (stroke) and traumatic brain injury (Cotman and Anderson, 1995; Lassmann et al., 1995; Bredesen 1995; Du et al., 1996 Chopp et al., 1996). Although the precise cellular mechanism underlying apoptosis especially in mammalian neurons is poorly understood, it has become apparent that apoptosis, like the cell cycle, is not a simple metabolic cascade but is the result of a rather complex set (programmed in many cells) of molecular interactions between several proteins.

Recently, two families of aspartyl-specific cysteine proteases have been identified in the nematode Caenorhabditis elegans and shown to be critical for the programmed cell death via apoptosis of neurons during nematode development. Mammalian homologues of these cysteine proteases (designated caspases) (Alnemri et al., 1996) also have been identified, and data are accumulating that these subserve important roles in mediating apoptosis of various mammalian cells (Gagliardini et al., 1994; Enari et al., 1995; Los et al., 1995). Moreover, the induced expression of single caspase, such as caspase-3 and mouse and human caspase-2, in transfected cell lines is sufficient to induce apoptosis (Miura et al., 1993; Kumar et al., 1994; Fernandes-Alnemri et al., 1995; Faucheu et al., 1995), which has been explained, at least partially, by the autocatalytic activity of these proteases (Wang et al., 1996). This phenomenon is also observed when the caspase-3 precursor (procaspase-3) is overexpressed in baculovirus (Xue and Horvitz, 1995).

Although several caspases have been identified in cells from the immune system and various tumor cell lines (Miura et al., 1993; Kumar et al., 1994; Fernandes-Alnemri et al., 1995), their regional and developmental expression in brain and their involvement in neuronal apoptosis for the most part have yet to be defined. Of the ten caspase genes cloned to date (Alnemri et al., 1996; Vaux and Strasser, 1996; Lippke et al., 1996; Liu et al., 1996), several have now been shown to be expressed in the central nervous system. Both the caspase-3 and caspase-2 genes, for example, are expressed in the brain and developmentally regulated (Kumar et al., 1994; Ni et al., 1997a). Only low levels of caspase-1 can be detected in the brain, principally in non-neuronal cells and in some interneurons (Bhat et al., 1996). In caspase-1–deficient mice, the central nervous system develops normally despite major defects in the caspase-1–dependent generation of mature interleukin-1 and other cytokines (Li et al., 1995; Kuida et al., 1995). In contrast, brain development is affected profoundly in caspase-3–deficient mice because of decreased neuronal apoptosis, but no discernible histologic abnormalities were observed in many peripheral tissues, such as heart, lung, liver, kidney, spleen, and testis (Kuida et al., 1996). These studies suggest that caspase-3 plays a critical role during morphogenetic cell death of mammalian neurons.

After transient global ischemia, CA1 pyramidal neurons of the hippocampus degenerate in a characteristic fashion in several species (Pulsinelli and Brierley, 1979; Pulsinelli et al., 1982). The transient global ischemia model has been used extensively to identify intrinsic mechanisms underlying delayed neuronal cell death (Kirino 1982; Kirino and Sano, 1994). Moreover, CA1 pyramidal neurons undergo selective and delayed cell death in humans after global ischemia, such as that which occurs after myocardial infarction. The delayed cell death of CA1 pyramidal neurons after transient global ischemia appears to be apoptotic in nature, based on classic criteria for defining apoptosis, including alterations in cellular and nuclear morphology by light and electron microscopy and the presence of internucleosomal DNA fragmentation as determined by in situ TUNEL labeling (MacManus et al., 1993; Kihara et al., 1994; Nitatori et al., 1995), although necrosis also is implicated (Deshpande et al., 1992). In the present study, we measured the expression of the transcript for caspase-3 in various regions of the adult rat brain after transient global forebrain ischemia. Our data suggest that a prolonged transcriptional activation of caspase-3 may be involved in the delayed degeneration of CA1 pyramidal neurons after global ischemia.

MATERIALS AND METHODS

Four-vessel occlusion

Transient forebrain ischemia was induced by four-vessel occlusion according to the method of Pulsinelli and Brierley (1979). Briefly, male Wistar rats (250–270 g; Hilltop Laboratories, Scottsdale, PA, U.S.A.) were prepared for forebrain ischemia under halothane anesthesia by electrocauterizing the vertebral arteries bilaterally and placing atraumatic carotid clasps around the common carotid arteries without interrupting the arterial blood flow. On the following day, forebrain ischemia was induced by tightening the clasps for 30 minutes. Three animals were not subjected to ischemia and served as controls. One, 2, 3, and 4 days after ischemia, animals (3–5 animals per time point) were killed and the brains processed as described in the following section. The animals were removed from anesthesia during the period of ischemia. All animal procedures were performed in compliance with and following approval of the Lilly Research Laboratories Animal Care and Use Committee.

Probe labeling

35S-labeled sense and antisense RNA probes were synthesized by in vitro transcription of caspase-3 (Ni et al., 1995) and caspase-2 cDNAs as described by Stratagene, and used for in situ hybridization, as described previously (Ni et al., 1995). RNA probes were shortened to an average length of 150 base pair by alkaline hydrolysis before hybridization (Ni et al., 1995).

Tissue preparation

Forebrains were dissected rapidly and frozen in isopentane, chilled using dry ice, and serially sectioned in the coronal plane throughout the rostrocaudal extent of the hippocampus. Twenty-micrometer thick sections were used for immunocytochemistry, and 15-μm thick sections were used for in situ hybridization. Regions evaluated included only those the same coronal plane as the hippocampus.

In situ nick end labeling

Frozen sections were postfixed in 4% buffered paraformaldehyde (pH 7.4) and subsequently labeled using the Apotag in situ apoptosis detection kit (peroxidase) according to manufacturer's recommendations (Oncor, Gaithersburg, MD, U.S.A.). Briefly, sections were equilibrated, incubated at 37°C with terminal deoxynucleotidyl transferase (Tdt) and digoxigeninnucleotide for 1 hour, followed by antidigoxigenin-peroxidase. The reaction product was visualized using diaminobenzidine/H₂O₂; sections were counterstained with methyl green, dehydrated, and mounted using permount. For negative controls, sections from sham-operated controls also were stained in parallel as aforementioned; moreover, sections from animals subjected to forebrain ischemia were incubated with the Tdt enzyme alone.

Immunocytochemistry

Immunocytochemistry was performed using the monoclonal antibody OX42 (Bioproducts for Science, Indianapolis, IN, U.S.A.). This antibody identifies the CR3 complement receptor expressed on activated microglia (Graeber et al., 1988; Gehrmann et al., 1992). Frozen sections were postfixed in 3.7% formalin (5 minutes), followed by acetone (50% acetone, 2 minutes; 100%, 3 minutes; 50%, 2 minutes) and then quenched for 30 minutes in 0.25% H₂O₂ in 10% nonbuffered formalin. Immunocytochemistry was performed using the avidin-biotin peroxidase system (ABC kit, Vector Labs, Burlingame, CA, U.S.A.).

In situ hybridization histochemistry

In situ hybridization analysis was performed as described in detail elsewhere (Ni et al., 1995 and 1997b). Briefly, frozen sections (15 μm) were prepared on a cryostat, mounted on poly-L-lysine—coated glass slides and dried at room temperature. Before hybridization, sections were warmed to 25°C, fixed in 4% formaldehyde, and immersed for 10 minutes in 0.25% acetic anhydride, 0.1 mol/L triethanolamine hydrochloride, and 0.9% sodium chloride (NaCl). The 35S-labeled riboprobes were added to a hybridization buffer composed of 50% formamide, 0.3 mol/L NaCl, 20 mmol/L TRIS-hydrochloride (pH 8), 5 mmol/L edetic acid, 500 μg tRNA/mL, 10% dextran sulfate, 10 mmol/L dithiothreitol, and 0.02% each of bovine serum albumin, ficoll, and polyvinylpyrrolidone. The slides then were incubated in a humidified chamber overnight at 55°C. Then the sections were treated with RNase A (20 μg/mL) for 30 minutes at room temperature, followed by a 15-minute wash in 0.1 xSSC at 55°C. For analysis at the cellular level, the slides were dipped in Kodak NTB3 nuclear emulsion, stored with desiccant at 4°C for 10 days, developed, and counterstained with hematoxylin/eosin-phloxine for microscopic evaluation. The hybridization signal was visualized by bright-field microscopy and densitometrically analyzed using NIH Image (Bethesda, MD, U.S.A.). Caspase-3 mRNA levels were measured in the CA1 region of CA1/CA2 borderline. Seventy-two hours after ischemia, nondegenerated CA1 regions were used to represent the caspase-3 mRNA level. The means of arbitrary density from five to ten images of three to five animals per time point are normalized by using the ratio of CA1/cortex.

RESULTS

Expression of caspase-3 mRNA in CA1 pyramidal neurons after transient forebrain ischemia

CA1 pyramidal neurons of the hippocampus are selectively vulnerable to transient ischemic injury. In agreement with previous studies (Pulsinelli and Brierley, 1979; MacManus et al., 1993; Kihara et al., 1994; Nitatori et al., 1995), 30 minutes of transient global forebrain ischemia resulted in selective degeneration (apoptosis) of neurons in the hippocampal CA1 region more than 72 hours after ischemia, based on the classic criteria for apoptosis, such as condensation of nuclear chromatin (hematoxylin-and-eosin staining), in situ labeling of DNA fragmentation (TUNEL labeling), and CA1 microglial activation (OX42 immunoreactivity), as shown in Fig. 1.

FIG. 1.

Apoptotic cell death of CA1 pyramidal neurons after transient global ischemia. Sections were from animals subjected to 30 minutes of global forebrain ischemia and examined with hematoxylin-and-eosin (H&E) staining (A), TUNEL labeling (B), and CR3 complement receptor staining (C) 96 hours after ischemia. (A) Photomicrograph of H&E-stained section of the CA1 region. CA1 pyramidal neurons show pyknosis, eosinophilia, karyorrhexis, and chromosome condensation. Nuclear fragmentation is observed (arrowhead). (B) TUNEL labeling of CA1 pyramidal neurons. Nuclei are strongly labeled in most pyramidal neurons (arrowhead). (C) CR3 complement receptor, which is expressed only on activated microglia (Graeber et al., 1988; Gehrmann et al., 1992), is intensely labeled by monoclonal antibody OX42, and the immunoreactivity is intensively concentrated in the CA1 pyramidal layers after transient global ischemia. No nuclei/chromatin condensation, TUNEL labeling, or OX42 immunoreactivity are observed in CA1 regions of sham animals (data not shown). Bar = 20 μm.

To evaluate whether transient forebrain ischemia activates the transcription of caspase-3 gene, we employed in situ hybridization histochemistry to measure caspase-3 mRNA in the CA1 regions of hippocampus. As shown in Fig. 2, hybridization with the 35S-labeled caspase-3 probe revealed an induction of caspase-3 mRNA in the CA1 pyramidal cell layer of the hippocampus 24, 48, and 72 hours after transient forebrain ischemia (Fig. 2A–C). Prolonged caspase-3 mRNA expression in the CA1 region was evident because a robust and selective increase in caspase-3 mRNA was observed in CA1 pyramidal neurons 72 hours after ischemia but not in adjacent pyramidal neurons of CA2-CA4 regions or in neurons of the cerebral cortex. An anticipated reduction in caspase-3 was found in CA1 pyramidal neurons 96 hours after ischemia, when CA1 neurons show severe cell damage, suggesting that loss of caspase-3 mRNA is caused by loss of viability of caspase-3–expressing CA1 neurons. A transient increase in caspase-3 mRNA expression is observed in the CA3 region of the hippocampus 24 hours after ischemia, but levels of caspase-3 mRNA are similar to controls by 48 hours after ischemia (Fig. 2A and 2E). It appears that caspase-3 mRNA is induced in virtually all CA1 pyramidal neurons, including those in the paramedian zone 24 hours after ischemia, but it is reduced or absent in CA1 neurons of the paramedian zone, which are most sensitive to ischemic injury and which have degenerated by 72 hours after ischemia.

FIG. 2.

Transient forebrain ischemia induces any early and prolonged expression of caspase-3 mRNA in CA1 neurons. Cryostat-prepared tissue sections were hybridized with caspase-3 riboprobe and processed for in situ hybridization histochemistry, as described in the Materials and Methods section. In addition to the sham control (A), four postischemic time points were included: (B) 24, (C) 48, (D) 72, and (E) 96 hours. The hybridization signal was visualized by bright-field microscopy (A–E) and was analyzed densitometrically using NIH Image (NIH, Bethesda, MD, U.S.A.) (F). (A–E) Ischemia resulted in induction of caspase-3 mRNA in the CA1 pyramidal cell layer at 24, 46, and 72 hours, respectively. Prolonged induction in the expression of caspase-3 mRNA in certain CA1 region appears to be robust and selective 72 hours after ischemia. Reduction in caspase-3 mRNA was found in CA1 pyramidal neurons 96 hours after ischemia, when CA1 neurons show severe cell damage. (F) Densitometric analysis of caspase-3 mRNA levels in the CA1 region. The CA1 regions on the CA1/CA2 borderline was measured (see Materials and Methods section for detail). The means of arbitrary density from five to ten images of three to five animals per time point are normalized by using the ratio of CA1/Ctx. Ctx, cortex; Hp, hippocampus.

To examine whether the loss of caspase-3 mRNA in these neurons is caused by a loss of cell viability, we examined sections of hippocampus that showed varying degrees of damage 72 hours after ischemia (i.e., when delayed cell death begins to occur). As shown in Fig. 3, caspase-3 mRNA is induced in CA1 neurons that do not yet show ischemic damage (i.e., no nuclear condensation), whereas neurons showing ischemic damage (i.e., nuclear condensation) lack caspase-3 mRNA, suggesting that caspase-3 mRNA is induced in CA1 pyramidal neurons that are committed to die but have not yet degenerated. These data are in agreement with the observation that at later time points after ischemia (e.g., 96 hours), most CA1 neurons have died and little caspase-3 mRNA can be detected (Fig. 2C).

FIG. 3.

Induction of caspase-3 transcripts in committed but not dead CA1 neurons. Hybridization with caspase-3 antisense probe resulted in a strong hybridization signal in the CA1 pyramidal layer of hippocampus 72 hours after transient global ischemia (A). Low levels of caspase-3 mRNA in the same cellular layer of the sham (control) animal are shown in (B). Cellular distribution of caspase-3 mRNA in both hippocampus shown in (A) is demonstrated in (C) and (D), respectively. The hybridizational signal was not present over pyramidal neurons, which showed condensed nuclei (solid arrowhead) (C), but highly elevated in neurons with intact nuclei morphology (open arrowhead), as also observed in most pyramidal neurons in (D).

To further confirm the induced expression of caspase-3 mRNA after transient global ischemia, we measured the expression of another gene encoding a brain specific Na⁺-dependent phosphate cotransporter, (rBNPI), previously shown to be expressed in CA1 hippocampal neurons (Ni et al., 1995). rBNPI mRNA is expressed abundantly in the rat hippocampus and is reduced specifically in CA1 pyramidal neurons after transient global ischemia (Ni et al., 1997b). As shown in Fig. 4, in near-adjacent sections, rBNPI mRNA is selectively reduced after global ischemia in CA1 neurons of hippocampus 72 hours after ischemia, whereas caspase-3 mRNA is dramatically induced.

FIG. 4.

Specific induction of caspase-3 mRNA in the CA1 neurons. Ischemic insult resulted in a delayed cell death associated with a dramatic decrease in sodium-dependent Pi cotransporter (BNPI) mRNA in CA1 region (Ni et al., 1997b) (A) In near adjacent section, caspase-3 mRNA is induced in the CA1 pyramidal neurons 72 hours after ischemia (B).

Differential expression of the caspase-3 and caspase-2 genes after transient global ischemia

To further evaluate the specificity of caspase-3 gene expression after transient global ischemia, we examined the expression of another member of caspase family, caspase-2, using in situ hybridization on near-adjacent sections. Caspase-2 also is expressed in neurons of the rat brain and CA1 pyramidal neurons of the hippocampus in particular (Kumar et al., 1994). As shown in Fig. 5, in situ hybridization of caspase-3 and caspase-2 mRNAs revealed a markedly different pattern of expression. Although there is an increase in caspase-2 mRNA in the cerebral cortex 24 hours after ischemia, no significant change in caspase-2 mRNA (compared with controls) is observed in the CA1 cell layer of the hippocampus 24 or 72 hours after ischemia. By contrast, the levels of caspase-3 mRNA are increased in the CA1 region as measured in near-adjacent sections, suggesting that transient forebrain ischemia may selectively induce the expression of caspase-3 in this brain region.

FIG. 5.

Differential expression of caspase-3 and caspase-2 mRNAs in the rat brain after ischemic insult. Expression of caspase-3 and caspase-2 mRNA, a closely related cell death cysteine protease, at various time points after ischemic insult is shown. No significant induction or loss of caspase-2 mRNA is observed in the CA1 pyramidal layer of hippocampus 24 or 72 hours after ischemia, although an induction of caspase-2 mRNA is observed in the cerebral cortex 24 hours after ischemia (top). By contrast, the caspase-3 gene is induced in the CA1 pyramidal layer of the hippocampus using near-adjacent sections (bottom).

DISCUSSION

To our knowledge, our data represent the first demonstration of a prolonged increase in the expression of caspase-3 in CA1 pyramidal neurons of the hippocampus after transient global ischemia. These neurons have been shown previously to undergo a rather selective delayed-type of degeneration that is apoptotic in nature. In contrast, there was no change in the expression of caspase-2 mRNA, a closely related member of caspase family in the CA1 pyramidal neurons, when measured in near-adjacent sections. The early and prolonged induction of caspase-3 mRNA in CA1 neurons that are committed to apoptotic cell death but that are not yet dead suggests that caspase-3 may well mediate neuronal apoptosis in this model.

Using in situ hybridization histochemistry, we characterized the cellular localization of caspase-3 mRNA expression in neurons of the cerebral cortex and hippocampus and relatively higher levels of expression in granule neurons of the cerebellum. The physiologic significance of this constitutive expression vis-à-vis the role of caspase-3 in neuronal apoptosis still is unclear. It is curious that mRNA for a cell death gene is expressed even at low levels in cells/neurons not undergoing apoptosis. Conceivably, however, not all caspase-3 mRNA is translated into functional protein or, alternatively, there may be a critical level or concentration of protein necessary for induction of apoptosis. Moreover, the caspase-3 proenzyme, like most members of caspase family, must be processed proteolytically to catalytically active subunits and therefore, other factors may regulate the processing of the caspase-3 proenzyme encoded by the mRNA measured in our experiments. Finally, native or endogenous inhibitors of caspase-3 may exist to prevent caspase-3–mediated apoptosis. It appears that other caspase-1–related proteases are expressed at low levels in certain tissues in which cells apparently are not undergoing apoptosis, suggesting that these cysteine-related proteases are involved in cellular functions other than cell death when present at “normal” levels. Caspase-1 itself usually is involved in converting prointerleukin-1β to active interleukin-1β (Black et al., 1989; Kostura et al., 1989).

Mammalian cells that overexpress genes for members of caspase family, including caspase-3, die via apoptosis (Miura et al., 1993; Kumar et al., 1994; Fernandes-Alnemri et al., 1995). Thus, increased expression of caspase-3 mRNA in CA1 hippocampal neurons—if accompanied by increased protein and catalytically active protease activity—may contribute (or mediate) their delayed death via apoptosis. Previous experiments have demonstrated that intraventricular administration of cycloheximide, a protein synthesis inhibitor, attenuates ischemia-induced cell death of hippocampal neurons (Goto et al., 1990; Shigeno et al., 1990) including CA1 pyramidal neurons, suggesting that transcriptional or translational activation of an ischemia-induced genetic program may contribute to apoptotic cell death after ischemia. Moreover, the antiapoptotic gene bcl-2 appears to protect against ischemia-induced neuronal cell death after either global or focal ischemia (Shimazaki et al., 1994; Chen et al., 1995). However, several reports have shown that protein synthesis such as HSP72 was suppressed after ischemia (Nowak, 1991). We do not know yet whether the rather robust increase in caspase-3 mRNA expression is accompanied by a similar increase in translated protein. Currently, we cannot confirm an increase in caspase-3 protein because of the lack of specific antisera necessary for such studies.

We also observed a transient increase in caspase-3 mRNA in CA3 neurons 24 hours after ischemia. However, these neurons do not show delayed cell death after transient global ischemia such as that employed in our study. This seemingly paradoxical observation may be explained by the recent finding that the antiapoptotic proto-oncogene bcl-2 also is induced in hippocampal CA3 neurons and granule neurons of the dentate gyrus (but not in CA1 pyramidal neurons) after ischemia (Chen et al., 1996). Thus, the transient elevation of caspase-3 mRNA expression in CA3 neurons may be balanced by the inhibitory effect of induced bcl2 expression. Alternatively, the transient and relatively minor elevation of caspase-3 mRNA may not be sufficient to induce cell death of CA3 neurons. Recent studies also have shown up-regulation of bcl2-related proteins, such as Bax and induced Bax transcripts in CA1 neurons after transient global ischemia (Krajewski et al., 1995; Chen et al., 1996). The increased expression of Bax may play a role in abrogating the ability of bcl-2 to suppress apoptosis by dimerizing with bcl-2. These observations are consistent with the fact that programmed cell death for any given population of cells occurs by a mechanism orchestrated by several proteins that may either promote or inhibit apoptosis, but that ultimately require cysteine proteases (Gagliardini et al., 1994; Milligan et al., 1995; Enari et al., 1995; Los et al., 1995). The possible involvement of cysteine protease(s) in ischemia-induced CA1 cell death also is supported by the observation that inhibition of proteolysis protects hippocampal neurons from ischemia-induced CA1 cell death (Lee et al., 1991). Finally, although caspase-1 mRNA expression has been shown recently to be increased in the hippocampus after transient global ischemia, the increased caspase-1 immunoreactivity was in this case localized to microglia, suggesting an indirect role of caspase-1 in neuronal damage after ischemia (Bhat et al., 1996).

Our observation of a differential expression of caspase-3 and caspase-2 mRNAs in response to transient global ischemia suggests that ischemia can selectively induce certain cell death proteases, presumably as a part of the mechanism underlying the apoptotic cascade. The transcriptional activation of caspase-3 mRNA in CA1 pyramidal neurons, which are committed to undergo apoptosis after ischemic injury, is consistent with our recent findings on cultured cerebellar granule neurons, in which an early and prolonged up-regulation of caspase-3 mRNA by apoptotic insults (e.g., reduced extracellular [K⁺]) is followed by apoptotic cell death (Ni et al., 1997a). Moreover, down-regulation of the overexpressed caspase-3 mRNA by exposure to neurotrophic factors, such as brain-derived neutrotrophic factor, or depolarization with [K⁺] will protect these neurons if such treatments are applied before the commitment point for apoptosis induced by K⁺ withdrawal (Ni et al., 1997a). Significantly, neuronal injury/death in the rat brain after ischemia (Hara et al., 1997) and in cultured cerebellar granule neurons by reduced extracellular K+/serum (Armstrong et al., 1997) are greatly attenuated by inhibitors of caspase-3 and caspase-1, suggesting a role for caspase-3 in neuronal apoptosis in vivo and in vitro.

It appears from our studies that the caspase-3 gene is readily inducible and may serve as a biological sensor to govern cell fate after metabolic or toxic insults. However, it seems unlikely that any single protease is solely responsible for ischemia-induced apoptosis of neurons in the mammalian central nervous system (Martin and Green, 1995). We cannot rule out the involvement of other members of caspase family in CA1 hippocampal cell death after ischemia. Although caspase-2 is unlikely to be involved directly in ischemia-induced CA1 pyramidal cell death, a possible role for caspase-2 in ischemia-induced apoptosis of other populations of neurons (e.g., in the cerebral cortex) is under investigation. Nonetheless, the existing data suggest that the development of brain-penetrable inhibitors of caspase-3 may be a useful therapeutic approach to preventing the delayed neurodegeneration that occurs after global or focal ischemic brain injury.

Footnotes

Acknowledgment

The authors thank Dr. S. Kumar for kindly providing caspase-2 cDNA.

References

Alnemri

Livingston

Nicholson

(1996) Human ICE/CED-3 protease nomenclature. Cell 87:171.

Armstrong

Aja

Hoang

(1997) Activation of the CED/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not neurosis. J Neurosci 17:553–562.

Bhat

DiRocco

Marcy

(1996) Increased expression of IL1β converting enzyme in hippocampus after ischemia: selective localization in microglia. J Neurosci 16:4146–4154.

Black

Kronheim

Sleath

(1989) Activation of interleukin-1 beta by a co-induced protease. FEBS Lett 247:386–390.

Bredesen

(1995) Neural apoptosis. Ann Neurol 38:839–851.

Chen

Graham

Chan

Lan

Zhou

Simon

(1995) bcl-2 is expressed in neurons that survive focal ischemia in rat. Neuroreport 6:394–398.

Chen

Zhu

Nakayama

(1996) Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J Neurochem 67:64–71.

Chopp

Chan

Hsu

Cheung

Jacobs

(1996) DNA damage and repair in central nervous system injury. Stroke 27:363–369.

Cotman

Anderson

(1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10:19–45.

10.

Deshpande

Bergstedt

Linden

Kalimo

Wieloch

(1992) Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: evidence against programmed cell death. Exp Brain Res 88:91–105.

11.

Csernansky

Hsu

Choi

(1996) Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 16:195–201.

12.

Enari

Hug

Nagata

(1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78–81.

13.

Faucheu

Diu

Chan

(1995) A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 14:1914–1922.

14.

Fernandes-Alnemri

Litwack

Alnemri

(1995) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269:30761–30764.

15.

Gagliardini

Fernandez

Lee

RKK

(1994) Prevention of vertebrate neuronal death by the crmA gene. Science 263:816–828.

16.

Gehrmann

Bonnekoh

Miyazawa

Hossmann

K-A

Kreutzberg

(1992) Immunocytochemical study of an early microglial reaction in ischemia. J Cereb Blood Flow Metab 12:257–269.

17.

Goto

Ishige

Sekiguchi

(1990) Effepts of cycloheximide on delayed neuronal death in rat hippocampus. Brain Res 534:299–302.

18.

Graeber

Tetzlaff

Streit

Kreutzberg

(1988) Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett 85:317–321.

19.

Hara

Friediander

Gagiiardini

(1997) Inhibition of interleukin-1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94:2007–2012.

20.

Jacobson

Weil

Raff

(1997) Programmed cell death in animal development. Cell 88:347–354.

21.

Kerr

JFR

Wyllie

Currie

(1972) Apoptosis: a basic biological phenomenon with wide ranging implication in tissue kinetics. Br J Cancer 26:239–243.

22.

Kirino

(1982) Delayed neuronal death in the gerbil hippocampus following transient ischemia. Brain Res 239:57–69.

23.

Kirino

Sano

(1984) Selective vulnerability in the gerbil hippocampus following transient forebrain ischemia. Acta Neuropathol 62:201–208.

24.

Kihara

Shiraishi

Nakagawa

Toda

Tabuchi

(1994) Visualization of DNA double strand breaks in the gerbil hippocampal CA1 following transient ischemia. Neurosci Lett 175:133–136.

25.

Kostura

Tocci

Limjuco

(1989) Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 86:5227–5231.

26.

Krajewski

Mai

Krajewska

Sikorska

Mossakowski

Reed

(1995) Upregulation of Bax protein levels in neurons following cerebral ischemia. J Neurosci 15:6364–6376.

27.

Kuida

Lippke

(1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000–2003.

28.

Kuida

Zheng

(1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368–372.

29.

Kumar

Kinoshita

Noda

Copeland

Jenkins

(1994) Induction of apoptosis by mouse Nedd2 gene which encodes a protein similar to the product of Caenorhabditis elegans cell death gene ced-3 and mammalian IL-1β-converting enzyme. Gene Dev 8:1613–1626.

30.

Lassmann

Bancher

Breitschopf

(1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89:35–41.

31.

Lee

Frank

Vanderklish

Arai

Lynch

(1991) Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88:7233–7237.

32.

Allen

Banerjee

(1995) Mice deficient in IL-1β converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401–411.

33.

Lippke

Sarnecki

Caron

MS-S

(1996) Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J Biol Chem 271:1825–1828.

34.

Liu

X-S

Kim

Pohl

Wang

(1996) Purification and characterization of an interleukin-1β converting enzyme family of protease at activates cysteine protease p32 (CPP32). J Biol Chem 271:13371–13376.

35.

Los

Van de Craen

Penning

(1995) Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375:81–83.

36.

MacManus

Buchan

Hill

Rasquinha

Preston

(1993) Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett 164:89–92.

37.

Martin

Green

(1995) Protease activation during apoptosis: death by a thousand cuts? Cell 82:349–352.

38.

Milligan

Prevette

Homma

(1995) Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron 15:385–393.

39.

Miura

Rotello

Hartwieg

Yuan

(1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653–660.

40.

Yan

Wang

Paul

(1995) Regional expression and cellular expression of the Na+-dependent inorganic phosphate cotransporter of rat brain. J Neurosci 15:5789–5799.

41.

(1997a) Cloning and expression of a rat brain ICE-related protease (IRP) and its possible role in apoptosis of cultured cerebellar granule neurons. J Neurosci 17:1561–1569.

42.

Stephenson

Smalstig

Clemens

Paul

(1997b) Selective loss of neuronal Na+-dependent phosphate cotransporter mRNA in CA1 pyramidal neuron following global ischemia. Mol Brain Res 48:132–139.

43.

Nicholson

Ali

Thornberry

(1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37–43.

44.

Nitatori

Sato

Waguri

(1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001–1011.

45.

Nowak

Jr (1991) Localization of 70 kDa stress protein mRNA induction in gerbil brain after ischemia. J Cereb Blood Flow Metab 11:432–439.

46.

Pulsinelli

Brierley

(1979) A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10 267–272.

47.

Pulsinelli

Brierley

Plum

(1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491–498.

48.

Raff

Barres

Burne

Coles

Ishizaki

Jacobson

(1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695–700.

49.

Saunders

Jr (1996) Death in embryonic systems. Science 154:604–612.

50.

Shigeno

Yamasaki

Kato

(1990) Reduction of delayed neuronal death by inhibition of protein synthesis. Neurosci Lett 120:117–119.

51.

Shimazaki

Ishida

Kawai

(1994) Increase in bcl2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci Res 20:95–99.

52.

Vaux

Strasser

(1996) Molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239–2244.

53.

Wang

Zelenski

Yang

Sakai

Brown

Goldstein

(1996) Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 5:1012–1020.

54.

Wood

Dipasquale

Youle

(1993) In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 11:621–632.

55.

Xue

Horvitz

(1995) Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377:248–251.

Transient Global Forebrain Ischemia Induces a Prolonged Expression of the Caspase-3 mRNA in Rat Hippocampal CA1 Pyramidal Neurons

Abstract

Keywords

MATERIALS AND METHODS

Four-vessel occlusion

Probe labeling

Tissue preparation

In situ nick end labeling

Immunocytochemistry

In situ hybridization histochemistry

RESULTS

Expression of caspase-3 mRNA in CA1 pyramidal neurons after transient forebrain ischemia

Differential expression of the caspase-3 and caspase-2 genes after transient global ischemia

DISCUSSION

Footnotes

Acknowledgment

References